{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:59:31Z","timestamp":1792897171790,"version":"4.5.0"},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Psycho-Oncology"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer clinical trials often employ exclusion criteria that can impact vulnerable populations, particularly individuals with psychological, psychiatric, or neurological conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to analyze the prevalence and nature of exclusion criteria in clinical trials for prostate, breast, and lung cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The EU Clinical Trials Register identified 51 protocols uploaded between 2022 and 2024. Thematic content analysis categorized exclusion criteria, and the justifications provided, while frequency analysis quantified their prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After excluding five protocols (two non\u2010English and three inaccessible), the final dataset comprised 46 protocols: 13 for prostate cancer (22.8%), 24 for breast cancer (42.1%), and 9 for lung cancer (15.8%). Exclusion criteria targeting vulnerable populations were present in 78.3% of protocols, categorized into five themes:\n                      <jats:italic>psychiatric conditions<\/jats:italic>\n                      (24.6%),\n                      <jats:italic>neurological conditions<\/jats:italic>\n                      (22.8%),\n                      <jats:italic>other psychological conditions<\/jats:italic>\n                      (22.8%),\n                      <jats:italic>legal\/guardianship status<\/jats:italic>\n                      (5.3%), and\n                      <jats:italic>unspecified conditions<\/jats:italic>\n                      (24.6%).\n                      <jats:italic>Compliance concerns<\/jats:italic>\n                      (39.1%) were the most common justification, followed by\n                      <jats:italic>informed consent challenges<\/jats:italic>\n                      (32.6%),\n                      <jats:italic>safety risks<\/jats:italic>\n                      (13%),\n                      <jats:italic>drug interference<\/jats:italic>\n                      (10.9%), and\n                      <jats:italic>not in the best interest<\/jats:italic>\n                      (4.3%). Notably, 29.1% of protocols lacked justification for exclusions, raising ethical and transparency concerns.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The exclusion of vulnerable populations may limit the inclusivity and generalizability of cancer research. Heuristic biases and systemic practices can potentially influence this. Exploring the role of these factors and considering adaptive trial designs, along with providing detailed justifications for exclusion criteria, could support more equitable and representative clinical research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pon.70182","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T11:59:06Z","timestamp":1747051146000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols"],"prefix":"10.1002","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4794-1433","authenticated-orcid":false,"given":"Margherita","family":"Dah\u00f2","sequence":"first","affiliation":[{"name":"Department of Psychology Educational Science and Human Movement University of Palermo  Palermo Italy"},{"name":"WeSearch Lab \u2010 Laboratory of Behavioral Observation and Research on Human Development University of Palermo  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8238-2101","authenticated-orcid":false,"given":"Veronica","family":"Coppini","sequence":"additional","affiliation":[{"name":"Applied Research Division for Cognitive and Psychological Science IEO European Institute of Oncology IRCCS  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Applied Research Division for Cognitive and Psychological Science IEO European Institute of Oncology IRCCS  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferraris","sequence":"additional","affiliation":[{"name":"Applied Research Division for Cognitive and Psychological Science IEO European Institute of Oncology IRCCS  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Sanchini","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato\u2010Oncology University of Milan  Milan Italy"},{"name":"Centre for Biomedical Ethics and Law Department of Public Health and Primary Care KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Monzani","sequence":"additional","affiliation":[{"name":"Department of Psychology Educational Science and Human Movement University of Palermo  Palermo Italy"},{"name":"WeSearch Lab \u2010 Laboratory of Behavioral Observation and Research on Human Development University of Palermo  Palermo Italy"},{"name":"Applied Research Division for Cognitive and Psychological Science IEO European Institute of Oncology IRCCS  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Grasso","sequence":"additional","affiliation":[{"name":"Applied Research Division for Cognitive and Psychological Science IEO European Institute of Oncology IRCCS  Milan Italy"},{"name":"Department of Oncology and Hemato\u2010Oncology University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Agnello","sequence":"additional","affiliation":[{"name":"Department of Psychology Educational Science and Human Movement University of Palermo  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Badalamenti","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical Surgical and Critical Care (Me.Pre.C.C.) Section of Medical Oncology University of Palermo  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Algeri","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical Surgical and Critical Care (Me.Pre.C.C.) Section of Medical Oncology University of Palermo  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pravettoni","sequence":"additional","affiliation":[{"name":"Applied Research Division for Cognitive and Psychological Science IEO European Institute of Oncology IRCCS  Milan Italy"},{"name":"Department of Oncology and Hemato\u2010Oncology University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(22)00746\u2010x"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1420178"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241258589"},{"key":"e_1_2_11_5_1","volume-title":"Guideline for Good Clinical Practice E6 (R3)","author":"International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)","year":"2025"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12910\u2010022\u201000819\u20103"},{"key":"e_1_2_11_7_1","unstructured":"Council of Europe. \u201cConvention for the Protection of Human Rights and Dignity of the Human Being With Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine \u201d1997. Accessed Dec 6 2024 https:\/\/rm.coe.int\/168007cf98."},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2021.12.008"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.09.016"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-57896-0_2"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063\u2010019\u20103603\u20101"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-57896-0_2"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063\u2010023\u201007159\u20106"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2666\u20107568(22)00186\u20106"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/08989621.2022.2119136"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102693"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002529"},{"key":"e_1_2_11_18_1","volume-title":"StatPearls","author":"Leslie S. W.","year":"2023"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/17439760.2016.1262613"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2023.100435"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_147_16"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063\u2010020\u201004406\u2010y"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2023.2264216"},{"key":"e_1_2_11_25_1","volume-title":"Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects","author":"World Medical Association","year":"2024"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/17407745211056875"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45718-w"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.4236\/psych.2023.142016"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010\u20100285(73)90033\u20109"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063\u2010019\u20103603\u20101"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckz017"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2018.11.002"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1017\/s2045796019000866"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.7861\/fhj.2023\u20100059"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2022.1698"},{"issue":"9","key":"e_1_2_11_36_1","article-title":"Schizophrenia\u2010Like Psychosis Presented in a Patient With a Temporal Lobe Tumor: A Case Report","volume":"14","author":"Romero\u2010Luna G.","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1166714"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthplace.2023.102984"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq4994"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103373"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/medethics\u20102012\u2010100899"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.ccr\u201020\u20103854"}],"container-title":["Psycho-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pon.70182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:44:20Z","timestamp":1748342660000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pon.70182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1002\/pon.70182"],"URL":"https:\/\/doi.org\/10.1002\/pon.70182","archive":["Portico"],"relation":{},"ISSN":["1057-9249","1099-1611"],"issn-type":[{"value":"1057-9249","type":"print"},{"value":"1099-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2025-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70182"}}